Literature DB >> 27044730

Study of clinical and radiological profile and outcome in patients of intracranial hemorrhage.

Nilay N Suthar1, Khushali L Patel, Chirag Saparia, Ami P Parikh.   

Abstract

BACKGROUND: Incidence of intracerebral hemorrhage (ICH) is twice as high as in Western countries. Prognostic factors for predicting function outcome and mortality play a major role in determining the treatment outcome.
METHODS: A prospective study of male and female patients ≥12 years with primary nontraumatic intracranial hemorrhage were included. Hemorrhage caused by trauma, anticoagulant or thrombolytic drugs, brain tumor, saccular arterial aneurysm or vascular malformation were excluded. Functional outcome of patients was determined by modified Rankin's scale. Glasgow Coma Scale (GCS) score and ICH score were calculated for each patient.
RESULTS: Hypertension was present in 45 out of 49 patients (92%) with ICH of basal ganglia. Hypertension was significantly associated with worst clinical outcome. Mortality was high if the patient was comatose/stuporous compared to drowsy state (P < 0.0001). Mortality was found to be high when the size exceeded 30 cm3. High ICH score, low GCS score at the time of admission, presence of intraventricular hemorrhage, and midline shift were significantly associated with poor clinical outcome.
CONCLUSIONS: Intracranial hemorrhage can be deleterious if present with low GCS score, high ICH score, intraventricular extension, and midline shift.

Entities:  

Mesh:

Year:  2016        PMID: 27044730      PMCID: PMC5402816          DOI: 10.4103/1596-3519.176259

Source DB:  PubMed          Journal:  Ann Afr Med        ISSN: 0975-5764


Introduction

Intracerebral hemorrhage (ICH) is a common devastating neurologic event that causes high morbidity and mortality with profound economic implication. ICH will seem to continue to be an important problem in both India and other developed countries. Nontraumatic ICH occurs due to bleeding from a vascular source directly into the brain substance. It is a major public health problem[1] with an annual incidence of 10–30/100,000 population,[12] accounting for 2 million (10–15%)[3] of about 15 million strokes worldwide each year.[4] Approximately, 35–50% of patients with ICH die within the 1st month after bleeding.[56] Data from the Asian Stroke Advisory Panel revealed an incidence of ICH ranging from 17% to 33% of all strokes, twice as high as in Western countries.[7] Mortality depends on the size of the hematoma and on the location of the brain. Intracranial hemorrhages include ICH, subarachnoid hemorrhage (SAH), and intraventricular hemorrhage (IVH). Hemorrhages occurring into extradural or subdural spaces are usually associated with trauma. Traumatic causes of hemorrhages were not included in present study. Primary or hypertensive (spontaneous) ICH, ruptured saccular aneurysm and vascular malformations and hemorrhages associated with bleeding disorders account for most of the hemorrhage that present as stroke. Radiological studies such as computerized tomogram (CT) scan and magnetic resonance imaging have facilitated in locating and assessing the extent of insult precisely and deciding prognosis of the patient. Although several randomized therapeutic trials for ICH have been published, neither surgical nor medical treatments have been shown conclusively to benefit patients.[891011121314] However, early surgical intervention has shown mild statistically significant improvement in clinical outcome.[15] Prognostic factors for predicting function outcome and mortality thus play a major role in determining the treatment outcome.[56161718192021222324252627] Hospital admissions for ICH have increased by 18% in the past 10 years,[28] probably because of increases in the number of elderly people,[29] many of whom lack adequate blood pressure (BP) control, and the increasing use of anticoagulants, thrombolytics, and antiplatelet agents. Incidence might have decreased in some populations with improved access to medical care and BP control.[303132] Hence, we aimed to study, the clinical, radiological profile in patients of ICH. In clinical profile risk factors, symptomatology and physical findings were studied. In radiological profile, size, and location of hematomas, correlation of the size of hematomas with the short term prognosis (6 weeks) were also studied. We also studied mortality, morbidity, and predictive factors of clinical outcome of ICH.

Subjects and Methods

The study was started after obtaining approval from Institutional Review Board. The present study was conducted in the Medicine Department of a Tertiary Care Hospital in the Western part of India. Patients with intracranial hemorrhage during the period of November 2011–October 2013 were included. It is a prospective observational study. Hundred and nine patients with primary (nontraumatic) intracranial hemorrhage were included. Nine cases were excluded due to incomplete data. Male and females patients with age ≥12 years were included. Patients with intracranial hemorrhage (hemorrhage or bleeding within the skull) who have presented with a history of acute severe headache, altered sensorium, slurring of speech, acute hemiparesis, and accelerated hypertension – suggestive of acute cerebrovascular stroke and those who are presented with nontraumatic spontaneous hemorrhage were included. Patients whose hematoma was possibly caused by trauma, anticoagulant or thrombolytic drugs, brain tumor, saccular arterial aneurysm or vascular malformation were excluded. Patients with SAH, venous thrombosis, past history of intracranial hemorrhage, ischemic stroke, and those who underwent surgical intervention for it were excluded. All patients presenting with and fulfilling the inclusion criterion were included in this study after obtaining informed consents. Detailed relevant history and clinical examination were done according to predesigned and pretested protocol. All patients underwent CT imaging. Hematological and biochemical investigations like; complete blood counts, random blood sugar, renal function test, serum electrolytes, fasting serum lipid profile, prothrombin time with international normalized ratio, activated partial thromboplastin time, chest X-ray, electrocardiogram (ECG), two-dimensional (2D)-echocardiography with Doppler examination (2D echo), urine complete examination, ophthalmic fundus, and other investigations as and when required by standard laboratory techniques were done. The cases were studied in detail with emphasis on (1) contribution of risk factors particularly hypertension, (2) the level of consciousness on admission and improvement or deterioration thereafter and it's relation to prognosis, (3) the degree of motor weakness and mental functions and their recovery. CT scan was done on admission in all patients to confirm the diagnosis of ICH and to correlate the prognosis with the CT scan features according to the size of the hematoma in cm3 (length × width × thickness/2 in cm3) at various locations.[16] Other parameters in the CT scan were also included viz., the presence of ventricular extension, presence of midline shift and inferences correlated with prognosis. Management during the hospital stay included control of hypertension with appropriate antihypertensives, treatment of raised intracranial pressure with mannitol, maintenance of fluid and electrolyte balance, maintenance of airway, oropharyngeal suction, and Ryle's tube aspiration, general supportive measures to prevent bed sore, contractures. Treatment of intercurrent infections and associated complications were treated as per requirements. All the patients were followed up daily during the hospital stay and regularly thereafter until 6 weeks. Functional outcome of patients was determined by modified Rankin's scale (mRS).[33] Glasgow Coma Scale (GCS) score and ICH score[16] were calculated for each patient. ICH=Intracerebral hemorrhage, IVH=Intraventricular hemorrhage, GCS=Glasgow Coma Scale

Intracerebral hemorrhage score[16]

The data obtained was tabulated and was analyzed using proportion and percentages. Statistical Package for Social Science software (IBM Corp. Released 2011. IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM Corp.) was used for my statistical analysis. Different variables such as GCS score, ICH score, and its components, age, gender, BP, various risk factors of ICH were subjected to multiple regression analysis and were correlated with respect to clinical outcomes in term of mRS by GraphPad InStat software version 3.06 for Windows 95, (GraphPad Software, San Diego California USA, www.graphpad.com). Chi-square test was applied to calculate the mean value, 95% confidence interval (95% CI) of mean value and P value of hematoma size of all groups.

Results

Total 109 cases were taken for the study, but nine patients have to be excluded from study data due to insufficient data. The following observations were made from the data.

Age and gender

The mean age of the patients was 55.15 years. The majority of them were between 40 and 65 years. However, increased age was not associated with an increase in mortality. There were 62 males and 38 females.

Risk factors

Hypertension

This is the most consistent risk factor for ICH. In the present study, 88 patients had a diastolic BP of >100 mmHg on admission (88%). Mean BP calculated was 118.51 mmHg. Hypertension was present in 45 out of 49 patients (92%) with ICH of basal ganglia. In the case of lobar hemorrhages, 15 out of the 21 patients (71%) had hypertension while in the case of thalamic hemorrhages 12 out of 14 patients (86%) had hypertension. All the patients with cerebellar and brainstem hemorrhages were found to be hypertensive.

Diabetes mellitus

This is one of the major risk factors contributing to stroke. Hyperglycemia predisposes to hyperlipidemia and atherogenesis and thus perpetuates hypertension. In this study, 10 patients gave past history of diabetes mellitus. Mean 2-h postprandial blood sugar (PP2 BS) value was 153.99 mg/dl.

Ischemic heart disease, smoking, alcohol and family history

Ischemic heart disease (IHD), smoking and alcohol abuse and family history of cerebrovascular accident have been observed to be associated with an increased incidence of ICH, but not to the extent of hypertension.

Clinical presentation

There was considerable overlap of clinical features between all forms of ICH though there are different clinical features for different sites, the incidence of hypertension on admission in all forms of ICH correlated with other features of hypertension like left ventricular hypertrophy with or without strain pattern in ECG and hypertensive retinopathy. A headache was present in 41% of the patients more commonly seen with lobar hemorrhages. Vomiting occurred in 39% of patients, and 17% had seizures at onset. In most of them, the seizures were generalized tonic-clonic in nature. There was no association between seizures and hematoma size. A headache, vomiting and altered level of consciousness were seen in many patients, but their absence did not rule out ICH.

Level of consciousness on admission

Altered level of consciousness is one of the most common manifestations of ICH. Its severity varies according to the size and location of the hematoma. Stupor or coma was a bad prognostic sign. Altered level of consciousness was present in 63 patients. Bilateral upper motor neuron (UMN) signs and absent Doll's eye movement was significantly associated with high mRS score.

Fundoscopy, chest X-ray and electrocardiogram

Evidence of hypertensive retinopathy was present in 25 patients. Out of which 16 patients were expired (60%) (P = 0.0007). Papillodema was present in two patients, both of them get expired. The presence of hypertensive retinopathy may suggest prolonged, and uncontrolled hypertension and hence may be associated with a poor prognosis. Commonest chest X-ray finding was cardiomegaly (51%). The most common ECG findings were left ventricular hypertrophy (48%) followed by ST-T changes (16%) and sinus bradycardia (6%).

Various factors and outcome relation

Mean BP calculated: 118.51 mmHg was subjected to regression analysis in relation to mRS. (A: mRS) = −5.817 + 0.079 × (B: Mean BP). R2 = 11.80%. This is the percent of the variance in mRS explained by mean BP. The P < 0.0001, which was considered extremely significant. So hypertension was significantly associated with worst clinical outcome. PP2 BS value was also subjected to regression analysis in relation to mRS, the P = 0.019, which was also clinically significant. Hence, hyperglycemia was also significantly associated with clinical outcome. Mortality was high if the patient was comatose/stuporous compared to drowsy state (P < 0.0001). Impaired consciousness lasting for more than 48 h had a major impact on prognosis. Other features of significance from the prognostic point of view are bilateral UMN signs indicate a poor prognosis. In this study, 17 out of the 21 patients (81%) with this finding expired (P < 0.0001). The absence of Doll's eye movement was associated with increased mortality (P = 0.007).

Computerized tomogram scan aspects and outcome relation

Following parameters were studied in CT scan brain, site of the hematoma, size of the hematoma, midline shift, and intraventricular extension/IVH.

Site of hematoma

Most common site of ICH was basal ganglia (49%) followed by lobar (21%) and thalamus (14%). Mortality was 41% of all patients; it was highest in brain stem hematoma (67%) followed by a lobar hematoma (57%). Severe morbidity in term of mRS 4/5 was 15% in all patients; it was 21% in lobar, 14% in cerebellar, 14% in thalamus, 11% in the brainstem. IVH was highest in thalamus (43%) followed by lobar (38%) and basal ganglia (24%). Midline shift was highest in lobar (52%) and brainstem hematoma (44%) [Figure 1 and Table 1].
Figure 1

Site of hematoma

Table 1

Clinical outcomes, intraventricular hemorrhage and midline shift in relation to the location of intracranial hemorrhage

LocationMortalityMorbidityIVHMidline shift




nPercentagenPercentagenPercentagenPercentage
All patients (n=100)4141151527273434
Basal ganglia (n=49)173581612241429
Thalamus (n=14)857214643536
Lobar (n=21)6293218381152
Brainstem (n=9)667111111444
Cerebellar (n=7)4571140000

IVH=Intraventricular hemorrhage

Site of hematoma Clinical outcomes, intraventricular hemorrhage and midline shift in relation to the location of intracranial hemorrhage IVH=Intraventricular hemorrhage

Size of the hematoma versus prognosis in general

Overall mortality was 41%, and morbidity (mRS 3/4/5) was 15%. In the present study 39 patients had a hematoma size of ≤ 5 cm3, of which five patients (12.8%) died. One point which is worth noting is that all those five patients who died had brainstem hemorrhages. In the 5.1–15 cm3 group, out of the 22 patients four patients died (18.18%). Mortality rate was found to be high when the size exceeded 30 cm3 (24 out of 25, i.e., 96%) [Table 2].
Table 2

Outcome in relation to the size of the hematoma in general

Size in cm3Cases (n)Midline shiftVentricular extensionOutcome (mRS) at 6 weeks

mRS 1mRS 2mRS 3mRS 4mRS 5mRS 6Total
<53903218311539
5.1-152248211500422
15.1-30149711310814
>3025219001002425
Total10034272420122141100

The P value for mRS <3 versus mRS >3 is <0.0001. There is a significant linear trend among the ordered categories. mRS=Modified Rankin's scale

Outcome in relation to the size of the hematoma in general The P value for mRS <3 versus mRS >3 is <0.0001. There is a significant linear trend among the ordered categories. mRS=Modified Rankin's scale

Clinical outcome in relation to size of intracerebral hemorrhage

Size of the ICH (cm3) was high in patients who died (n = 41, mean size 37.63 cm3, 95% CI: 30.47–44.79) compared to patients who survived (n = 59, mean size 6.98 cm3, 95% CI: 5.38–8.58) (P < 0.0001) [Table 3].
Table 3

Size of intracerebral hemorrhage and its mean value in relation to mortality

Clinical outcome at 6 weeksNumber of patientsMean value (cm3)SDMSEM95% CI of meanP
All patients10019.5521.562.1615.23–23.87<0.0001
 Patients who died4137.6322.953.5830.47–44.79
 Patients who survived596.986.190.805.38–8.58

CI=Confidence interval, SEM=Standard error of mean, SDM=Standard deviation of mean

Size of intracerebral hemorrhage and its mean value in relation to mortality CI=Confidence interval, SEM=Standard error of mean, SDM=Standard deviation of mean The size of the ICH was high in patients who had significant disability mRS >3 (n = 44, mean size 35.81 cm3, 95% CI: 28.80–42.81) compared to patients who had mild or no disability mRS ≤3 (n = 56, mean size 6.71 cm3, 95% CI: 5.09–8.33) (P < 0.0001). The increase in the size of ICH was significantly associated with increased mortality and poor clinical outcome in the present study. Other studies Nag et al. 2012,[34] Hemphill et al. 2009,[35] Hallevy et al. 2002,[36] Zia et al. 2009[37] and Broderick et al. 1993[25] shows similar results [Tables 4, Figure 2].
Table 4

Size of intracerebral hemorrhage and its mean value in relation to clinical outcome (at 6 weeks) Modified Rankin's scale ≤3 and Modified Rankin's scale >3

Clinical outcome at 6 weeksNumber of patientMean value (cm3)SDMSEM95% CI of meanP
All patients10019.5521.562.1615.23-23.87<0.0001
Patients with mRS <3566.716.050.805.09-8.33
Patients with mRS >34435.8123.023.4728.80-42.81

CI=Confidence interval, SEM=Standard error of mean, SDM=Standard deviation of mean, mRS=Modified Rankin's scale

Figure 2

Clinical outcome in relation to intracerebral hemorrhage score

Size of intracerebral hemorrhage and its mean value in relation to clinical outcome (at 6 weeks) Modified Rankin's scale ≤3 and Modified Rankin's scale >3 CI=Confidence interval, SEM=Standard error of mean, SDM=Standard deviation of mean, mRS=Modified Rankin's scale Clinical outcome in relation to intracerebral hemorrhage score

Clinical outcome in relation to Glasgow Coma Scale score, intracerebral hemorrhage score, intraventricular hemorrhage, midline shift

Of all the 41 patients with ICH score 0, 39 had mRS <3, none died. Among 18 patients with ICH score 3, all patients died. All patients with ICH score 4 and 5 also died. The P value of mRS for ICH score is <0.0001 which is statistically highly significant. The increase in ICH score was associated with poor clinical outcome in the present study [Table 5].
Table 5

Clinical outcome in relation to Glasgow Coma Scale score, intracerebral hemorrhage score, intraventricular hemorrhage, midline shift

Number of patientsmRS <3mRS >3mRS 6χ2P mRS <3 versus mRS >3
ICH score
 041392168.08<0.0001
 1191632
 21711615
 31801818
 44044
 51011
 Total100564441
GCS score
 <8361353461.33<0.0001
 >8645597
 Total100564441
IVH
 Present271017165.398<0.05
 Absent73462725
 Total100564441
Midline shift
 Present347272526.217<0.0001
 Absent66491716
 Total100564441

GCS=Glasgow Coma Scale, ICH=Intracerebral hemorrhage, IVH=Intraventricular hemorrhage, mRS=Modified Rankin's scale

Clinical outcome in relation to Glasgow Coma Scale score, intracerebral hemorrhage score, intraventricular hemorrhage, midline shift GCS=Glasgow Coma Scale, ICH=Intracerebral hemorrhage, IVH=Intraventricular hemorrhage, mRS=Modified Rankin's scale Of all 100 patients, 36 patients had GCS score <8 at the time of admission, of which 35 had mRS score >3 and 34 died (P < 0.0001). IVH was present in 27 patients, of which 17 patients had mRS >3 and 16 died. 10 patients had mRS <3 [P = 0.005]. Midline shift was present in 34 patients of which 27 patients had mRS >3 and 25 were died (P < 0.0001).

Multiple regression analysis

With an objective to find out the impact of individual risk factor associated with higher mortality we have studied various variables such as age, size of ICH, mean BP, GCS score, ICH score, and they were subjected to multiple regression analysis in relation to clinical outcome in term of mRS score [Table 6].
Table 6

Multiple regression analysis of different variable with mortality

VariableBeta coefficientSE95% CI
Constant4.5381.7990.966-8.111
A: Age0.0140.012−0.011-0.038
B: Mean BP0.0030.012−0.020-0.026
C: GCS score−0.2690.049−0.366-−0.172
D: ICH score0.2720.170−0.066-0.610
F: Size0.0150.0060.003-0.028

GCS=Glasgow Coma Scale, ICH=Intracerebral hemorrhage, CI=Confidence interval, SE=Standard error, BP=Blood pressure

Multiple regression analysis of different variable with mortality GCS=Glasgow Coma Scale, ICH=Intracerebral hemorrhage, CI=Confidence interval, SE=Standard error, BP=Blood pressure Following results were obtained: Estimated mortality = 4.538 + 0.014 × (A: Age) + 0.003 × (B: Mean BP) −0.269 × (C: GCS) + 0.272 × (D: ICH) + 0.015 × (F: Size). Estimated mRS: 2.522 + 1.115 × (A: Age) + 0.258 × (B: Mean BP) −5.492 × (C: GCS) + 1.597 × (D: ICH) + 2.381 × (F: Size). 80.60% contribution in clinical outcome (mRS) at 6 weeks was made from five following variables: Age of the patient, mean BP control, the size of ICH, GCS score at admission and ICH score. That is to say, that size of ICH and GCS score at the time of admission were the most important predictor of clinical outcome [Table 7].
Table 7

Which variable(s) make a significant contribution to outcome?

VariableBeta coefficientPSignificance
Constant2.5220.013Yes
A: Age1.1150.268No
B: Mean BP0.2580.797No
C: GCS score−5.492<0.0001Yes
D: ICH score1.5970.114No
F: Size2.3810.019Yes

GCS=Glasgow Coma Scale, ICH=Intracerebral hemorrhage, BP=Blood pressure

Which variable(s) make a significant contribution to outcome? GCS=Glasgow Coma Scale, ICH=Intracerebral hemorrhage, BP=Blood pressure

Discussion

The incidence of ICH was highest in the age group 51–60 years (49% of the patients) in the present study. There was no significant gender difference observed. The distribution was similar to several other studies like Das Arjun study.[38]

Hypertension, diabetes mellitus, and ischemic heart disease

Hypertension was significantly associated with worst clinical outcome. Uncontrolled hypertension especially diastolic BP >100 mmHg was the most important risk factor in the present study. The majority of cases depending on the site of hemorrhage were associated with hypertension, especially cerebellar and brainstem hemorrhages. These findings were comparable to Das Arjun study.[38] Other factors, like left ventricular hypertrophy with or without strain pattern in ECG, hypertensive retinopathy indicated inadequately controlled hypertension were also with higher morbidity and mortality. Diabetes mellitus in our study was also a poor risk factor associated with worse clinical outcome. IHD, smoking, and alcohol abuse were less prominent risk factors in the present study.

Clinical presentation

Decreased level of consciousness on admission was associated with poor clinical outcome. The prognosis was worst in stuporous and comatose patients. Although symptoms such as a headache, vomiting, and altered level of consciousness were frequently seen, their absence did not rule out ICH with GCS <8. The occurrence of a headache (41%), vomiting (39%), and seizures (17%) were comparable with other similar studies like Mohr[39] and Pillai study.[40] Mortality was high if the patient was comatose. It can be concluded that impaired consciousness lasting for more than 48 h had a major impact on prognosis which is also seen several other studies. Bilateral UMN signs indicate a poor prognosis (P < 0.0001). The absence of Doll's eye movement is associated with increased mortality (P = 0.007). The presence of hypertensive retinopathy may suggest prolonged, and uncontrolled hypertension and hence may be associated[41] with a poor prognosis.

Mortality, morbidity, and various parameters

The most common site for intracranial hemorrhage in the present study was basal ganglia (49%) followed by lobar (21%), thalamus (14%), brainstem (9%), and cerebellum (7%). These findings were comparable with several Indian studies except Das Arjun study[38] were basal ganglia, and thalamic hemorrhage was observed less than lobar, brain stem, and cerebellar hemorrhages. Prakash and Bhavani et al.[4142] have similar sites of hemorrhage as our studies. The most important factors predicting the final outcome were the size of hematoma, intraventricular extension, midline shift, GCS score and ICH score. These results are comparable to results of an Indian study Nag et al. 2012[34] which also shows mean hematoma volume associated with death before 30 days is 33.16 cm3 (P < 0.0001), with survival after 30 days is 15.45 cm3 (P < 0.0001). Ventricular extension depends on the location of the hematoma, and the size and per se does not carry a poor prognosis with it. In the present study, out of total 27 patients having IVH, maximum IVH were associated with basal ganglia hemorrhages (44%). In the present study, 6 weeks outcome was good in patients with small hematoma ≤5 cm3 without midline shift or ventricular extension. Outcome worsened as the size of the hematoma increased. Mortality increased to 82% (32 out of 39 patients died) in patients having hematoma size >15 cm3. In the present study, mortality was higher in the case of brainstem hemorrhages (67%), followed by thalamic (57%) and cerebellar hemorrhages (57%). The most important factors predicting the final outcome were the size of hematoma, intraventricular extension, midline shift, GCS score and ICH score. These results indicated that high ICH score, low GCS score at the time of admission, presence of IVH, and midline shift were significantly associated with poor clinical outcome. Our these results are comparable to other studies like Nag et al. 2012,[34] Hemphill et al. 2009,[35] Hallevy et al. 2002,[36] Zia et al. 2009[37] and Broderick et al. 1993.[25] Ventricular extension depends on the location of the hematoma and the size and per se does not carry a poor prognosis. In this study, out of total 27 patients having IVH, maximum IVH were associated with basal ganglia hemorrhages (12/27 = 44%). However, surgical interventions early in the course of illness may change the course of illness. A small clinically relevant advantage has been noted by surgical trial in the intracerebral hemorrhage-II study when the early surgical intervention has been done in these cases of ICH.[15] However, the advantage may depend on surgical skill, infrastructure, and patient education. Timely surgical intervention may change outcome positively. Cerebral amyloid angiopathy is also one of the risk factors for the development of ICH, which also need to be studied. In the present study, 6 weeks outcome was good in patients with small hematoma ≤5 cm3 without midline shift or ventricular extension. Outcome worsened as the size of the hematoma increased. Mortality increased to 82% (32 out of 39 patients died) in patients having hematoma size >15 cm3. Mortality was relatively higher in the case of brainstem hemorrhages (67%), followed by thalamic (57%) and cerebellar hemorrhages (57%). These results compared with other studies and according to these four predictors: GCS score, mRS, ICH score, and age were proposed as variables directly influencing hospital mortality in ICH.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
ComponentICH score points
GCS score at presentation
 13-150
 5-121
 3-42
ICH volume (cm3)
 ≥301
 <300
IVH
 Yes1
 No0
Origin of ICH
 Infratentorial1
 Supratentorial0
Age
 ≥801
 <800
 Total ICH score0-6

ICH=Intracerebral hemorrhage, IVH=Intraventricular hemorrhage, GCS=Glasgow Coma Scale

  39 in total

1.  Incidence and trends of stroke and its subtypes in China: results from three large cities.

Authors:  Bin Jiang; Wen-zhi Wang; Honglei Chen; Zhen Hong; Qi-dong Yang; Sheng-ping Wu; Xiao-li Du; Qiu-ju Bao
Journal:  Stroke       Date:  2005-11-23       Impact factor: 7.914

2.  Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration.

Authors:  C L Sudlow; C P Warlow
Journal:  Stroke       Date:  1997-03       Impact factor: 7.914

3.  Intracerebral hemorrhage: external validation and extension of a model for prediction of 30-day survival.

Authors:  S Tuhrim; J M Dambrosia; T R Price; J P Mohr; P A Wolf; D B Hier; C S Kase
Journal:  Ann Neurol       Date:  1991-06       Impact factor: 10.422

Review 4.  Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century.

Authors:  Valery L Feigin; Carlene M M Lawes; Derrick A Bennett; Craig S Anderson
Journal:  Lancet Neurol       Date:  2003-01       Impact factor: 44.182

5.  Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study.

Authors:  L M Auer; W Deinsberger; K Niederkorn; G Gell; R Kleinert; G Schneider; P Holzer; G Bone; M Mokry; E Körner
Journal:  J Neurosurg       Date:  1989-04       Impact factor: 5.115

6.  The Harvard Cooperative Stroke Registry: a prospective registry.

Authors:  J P Mohr; L R Caplan; J W Melski; R J Goldstein; G W Duncan; J P Kistler; M S Pessin; H L Bleich
Journal:  Neurology       Date:  1978-08       Impact factor: 9.910

7.  Spontaneous supratentorial intracerebral hemorrhage. Criteria for short-term functional outcome prediction.

Authors:  Chen Hallevy; Gal Ifergane; Ella Kordysh; Yuval Herishanu
Journal:  J Neurol       Date:  2002-12       Impact factor: 4.849

8.  Three-year survival and stroke recurrence rates in patients with primary intracerebral hemorrhage.

Authors:  Elisabet Zia; Gunnar Engström; Peter J Svensson; Bo Norrving; Hélène Pessah-Rasmussen
Journal:  Stroke       Date:  2009-09-03       Impact factor: 7.914

9.  Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study).

Authors:  P M Rothwell; A J Coull; M F Giles; S C Howard; L E Silver; L M Bull; S A Gutnikov; P Edwards; D Mant; C M Sackley; A Farmer; P A G Sandercock; M S Dennis; C P Warlow; J M Bamford; P Anslow
Journal:  Lancet       Date:  2004-06-12       Impact factor: 79.321

10.  Prediction of Clinical Outcome in Acute Hemorrhagic Stroke from a Single CT Scan on Admission.

Authors:  Chiranjib Nag; Kamalesh Das; Mrinalkanti Ghosh; M R Khandakar
Journal:  N Am J Med Sci       Date:  2012-10
View more
  5 in total

Review 1.  Scoping Review and Commentary on Prognostication for Patients with Intracerebral Hemorrhage with Advances in Surgical Techniques.

Authors:  Stephanie Zyck; Lydia Du; Grahame Gould; Julius Gene Latorre; Timothy Beutler; Alexa Bodman; Satish Krishnamurthy
Journal:  Neurocrit Care       Date:  2020-08       Impact factor: 3.210

2.  Assessment and Comparison of the Four Most Extensively Validated Prognostic Scales for Intracerebral Hemorrhage: Systematic Review with Meta-analysis.

Authors:  Tiago Gregório; Sara Pipa; Pedro Cavaleiro; Gabriel Atanásio; Inês Albuquerque; Paulo Castro Chaves; Luís Azevedo
Journal:  Neurocrit Care       Date:  2019-04       Impact factor: 3.210

3.  Modifying the Intracerebral Hemorrhage Score to Suit the Needs of the Developing World.

Authors:  Ajay Hegde; Girish Menon
Journal:  Ann Indian Acad Neurol       Date:  2018 Oct-Dec       Impact factor: 1.383

4.  Computed tomography features of spontaneous acute intracranial hemorrhages in a tertiary hospital in Southern Ghana.

Authors:  Emmanuel Kobina Mesi Edzie; Klenam Dzefi-Tettey; Edmund Kwakye Brakohiapa; Philip Narteh Gorleku; Eric Aidoo; Kwasi Agyen-Mensah; Peter Appiah-Thompson; Adu Tutu Amankwa; Ewurama Andam Idun; Frank Quarshie; Richard Ato Edzie; Benard Osei; Prosper Dziwornu; Abdul Raman Asemah
Journal:  Pan Afr Med J       Date:  2021-12-16

5.  Clinical Profile and Predictors of Outcome in Spontaneous Intracerebral Hemorrhage from a Tertiary Care Centre in South India.

Authors:  Ajay Hegde; Girish Menon; Vinod Kumar; G Lakshmi Prasad; Lakshman I Kongwad; Rajesh Nair; Raghavendra Nayak
Journal:  Stroke Res Treat       Date:  2020-01-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.